This research explored how different prescription rules for phosphodiesterase-5 inhibitors (PDE-5Is) influence the handling of erectile dysfunction (ED) among men. A total of 10,000 men from Germany, Norway, Poland, and Switzerland participated in a survey that used the International Index of Erectile Function questionnaire. The tool helped detect men with ED and collect information about their treatment choices and personal experiences. The study also looked into the use of PDE-5 inhibitors among men who did not have ED.
A larger share of men with ED used PDE-5Is in Norway and Poland, where the drugs are sold over-the-counter, and in Switzerland, where they are dispensed by pharmacists, compared with Germany, where a doctor’s prescription is mandatory. In every country surveyed, pharmacy staff recommended that men considering buying PDE-5 inhibitors speak with a physician. Reliance on black-market sources for PDE-5 Inhibitors remained very low in areas where non-prescription purchase was permitted. Non-medical use of these medications was rare across all regions. Requiring a prescription for PDE-5 inhibitors can discourage men from pursuing treatment for ED and from identifying related health problems. For this reason, PDE-5Is should be made available without a prescription to strengthen ED care and motivate men to engage more actively with healthcare services.
